STUDIO CITY, CA –– June 27, 2018 –– Jason Kassin, CEO of FilmTrack, will receive the 2018 EMA Scholarship Foundation Honors Award for his service to the community. The award will be presented on Tuesday, July 17 during the Entertainment Merchants Association (EMA) Los Angeles Entertainment Summit at the Loews Hollywood Hotel in Los Angeles, California. Kassin is being recognized for his work on behalf of the Crohn’s & Colitis Foundation.
“It’s a Kassin family – and FilmTrack family – tradition to give back to the community in ways large and small,” says Kassin. “The Crohn’s & Colitis Foundation is dedicated to helping patients with these life-altering diseases via research, education, support, and advocacy. They have a measurable impact on people’s lives, and it’s been an honor to help draw attention to their cause.”
Kassin and his wife, Sasha, became involved with the Crohn’s & Colitis Foundation in 2011, a few months after their son, Conrad, was diagnosed with Crohn’s disease. Since then, Kassin and his family have been active volunteers for the Foundation. They’ve raised over $100,000 to date to help find a cure. Kassin joined the Los Angeles Board in 2016, and Sasha followed in 2017. This past January, Sasha became the President of the Board for the Greater Los Angeles Chapter.
The EMA Scholarship Foundation affords member companies the opportunity to provide the potential of educational assistance for employees as well as their spouses and children. Since its establishment in 1987, it has helped more than 240 students achieve higher education through scholarship grants totaling more than one million dollars. These grants provide selected students with up to $4,000 per year for up to four years.
To be eligible, students must be high school seniors or full-time undergraduate/graduate students during the academic year in which they apply. They must also be employees or principals of EMA member companies in good standing, or their spouse or child. Scholarships are awarded based on academic achievement, financial need, and academic potential.
To view EMA's press release honoring Jason Kassin, click here.
For more information on the EMA Scholarship Foundation, click here.
To learn more about the Crohn’s & Colitis Foundation, click here.
For over two decades, FilmTrack has been recognized as the leading SaaS rights management solution for the media & entertainment industry. The company’s cloud-based platform streamlines the complex intellectual property lifecycle, providing the necessary tools to manage mission-critical data, including contracts, rights, financials, royalties, and related assets.
About Entertainment Merchants Association
The Entertainment Merchants Association (EMA) is the not-for-profit international trade association dedicated to advancing the interests of the $35 billion home entertainment industry. Membership comprises the full spectrum of retailers (from single-store specialists to multi-line mass merchants, and both brick and mortar and online stores), distributors, the home video divisions of major and independent motion picture studios, video game publishers, and other related businesses that constitute and support the home entertainment industry. EMA was established in April 2006 through the merger of the Video Software Dealers Association (VSDA) and the Interactive Entertainment Merchants Association (IEMA).
About Crohn’s & Colitis Foundation
The Crohn's & Colitis Foundation is a non-profit, volunteer-driven organization dedicated to finding the cures for Crohn's Disease and ulcerative colitis, and to improving the quality of life of children and adults affected by these diseases. Since our founding nearly five decades ago, the Foundation has remained at the forefront of research in Crohn's disease and ulcerative colitis, collectively known as inflammatory bowel diseases (IBD). Today, we fund cutting-edge studies at major medical institutions, nurture investigators at the early stages of their careers, and finance underdeveloped areas of research. In addition, our professional education workshops and programs, along with our scientific journal, Inflammatory Bowel Diseases, enable medical professionals to keep pace with this rapidly growing field.
To view the official release, click here.